BioTrove Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

BioTrove General Information

Description

Developer of genomic analysis instruments and consumables designed for molecular diagnostics, high-throughput screening, and biotechnology research. The company's system executes multiple simultaneous and independent polymerase chain reactions across samples, enabling users to accelerate research and development across drug production and agricultural science sectors.

Contact Information

Website
www.biotrove.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 12 Gill Street
  • Suite 4000
  • Woburn, MA 01801
  • United States
+1 (781)
Primary Industry
Biotechnology
Acquirer
Invitrogen
Vertical(s)
Life Sciences
Corporate Office
  • 12 Gill Street
  • Suite 4000
  • Woburn, MA 01801
  • United States
+1 (781)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioTrove Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Merger/Acquisition 15-Dec-2009 Completed Generating Revenue
10. Later Stage VC (Series C1) 25-Feb-2009 Completed Generating Revenue
9. IPO 18-Dec-2008 Cancelled Generating Revenue
8. Later Stage VC (Series B1) 28-Feb-2006 Completed Generating Revenue
7. Later Stage VC 14-Jul-2005 Completed Generating Revenue
6. Later Stage VC 08-Jun-2005 Completed Product Development
5. Accelerator/Incubator 01-Jan-2005 Completed Product Development
4. Later Stage VC 02-Dec-2004 Completed Product Development
3. Later Stage VC (Series B) 14-Apr-2004 $13.7M $19M Completed Product Development
2. Later Stage VC 16-Oct-2002 $5.25M $5.25M Completed Startup
To view BioTrove’s complete valuation and funding history, request access »

BioTrove Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C1
Series C
Series B1
Series B
Series A1 45,802 $0.010000
Series A 250,000 $0.010000
To view BioTrove’s complete cap table history, request access »

BioTrove Patents

  • 99

    Total Documents Applications and Grants

  • Total Patents Families

  • 22

    Granted

  • Pending

  • Expiring in next 12 mo

BioTrove Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2010045462-A1 System for identification of multiple nucleic acid targets in a single sample and use thereof Inactive 15-Oct-2008
WO-2009132330-A2 Separation cartridges and methods for fabrication and use thereof Inactive 25-Apr-2008
WO-2009132330-A3 Separation cartridges and methods for fabrication and use thereof Inactive 25-Apr-2008
US-10106843-B2 Devices and methods for thermally-mediated chemical reactions Active 06-Mar-2008
US-20160160265-A1 Devices and methods for thermally-mediated chemical reactions Active 06-Mar-2008 B01L3/50851
To view BioTrove’s complete patent history, request access »

BioTrove Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Accretive Capital Partners Asset Manager Minority
Bio Frontier Partners Venture Capital Minority
CB Health Ventures Venture Capital Minority
Catalyst Health Ventures Venture Capital Minority
Echelon Ventures Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

BioTrove FAQs

  • When was BioTrove founded?

    BioTrove was founded in 1997.

  • Where is BioTrove headquartered?

    BioTrove is headquartered in Woburn, MA.

  • What industry is BioTrove in?

    BioTrove’s primary industry is Biotechnology.

  • Is BioTrove a private or public company?

    BioTrove is a Private company.

  • What is BioTrove’s current revenue?

    The current revenue for BioTrove is .

  • How much funding has BioTrove raised over time?

    BioTrove has raised $74.3M.

  • Who are BioTrove’s investors?

    Accretive Capital Partners, Bio Frontier Partners, CB Health Ventures, Catalyst Health Ventures, and Echelon Ventures are 5 of 13 investors who have invested in BioTrove.

  • When was BioTrove acquired?

    BioTrove was acquired on 15-Dec-2009.

  • Who acquired BioTrove?

    BioTrove was acquired by Invitrogen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process